USANA Health Sciences (NYSE:USNA) updated its FY 2021 earnings guidance on Thursday. The company provided earnings per share guidance of $5.800-$6.000 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.350. The company issued revenue guidance of $1.18 billion-$1.20 billion, compared to the consensus revenue estimate of $1.26 billion.USANA Health Sciences also updated its Q3 2021 guidance to $1.280-$1.330 EPS.
A number of equities analysts have recently commented on the company. Tigress Financial reiterated a buy rating and issued a $122.00 price objective on shares of USANA Health Sciences in a research note on Friday, October 8th. Zacks Investment Research upgraded USANA Health Sciences from a sell rating to a hold rating in a research note on Wednesday, September 29th.
USNA stock opened at $97.18 on Thursday. USANA Health Sciences has a twelve month low of $73.00 and a twelve month high of $107.85. The company has a market cap of $1.94 billion, a PE ratio of 14.66 and a beta of 0.85. The business’s 50-day simple moving average is $94.42 and its 200 day simple moving average is $98.19.
In other news, Director Gilbert A. Fuller sold 312 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, August 5th. The shares were sold at an average price of $96.52, for a total value of $30,114.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Robert A. Sinnott sold 1,648 shares of USANA Health Sciences stock in a transaction that occurred on Monday, August 16th. The shares were sold at an average price of $95.04, for a total transaction of $156,625.92. Following the completion of the transaction, the insider now owns 1,648 shares of the company’s stock, valued at approximately $156,625.92. The disclosure for this sale can be found here. Insiders have sold 3,435 shares of company stock worth $331,837 over the last ninety days. Company insiders own 0.21% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.
Recommended Story: Growth Stocks
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.